Shipments in India were slightly down year-over-year, as ordering delays seem to materialize with the weakening of the local currency. Our business in China held up well with sales up in the double-digit rate in the quarter and with all major customer segments delivering consistent growth. Developing markets in Eastern Europe, the Middle East and Latin America also were under pressure during the quarter and adversely impacted the division's overall sales growth. In these regions, nonlife science applications were most negatively affected.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts